Ensysce Biosciences (ENSC) Stock Statistics & Valuation Metrics

Ensysce Biosciences has a market cap or net worth of $4.36M. The enterprise value is $2.00M.

Ensysce Biosciences has 15,365,530 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ensysce Biosciences’s return on equity (ROE) is -3.17 and return on invested capital (ROIC) is >-0.01%.

The current PE Ratio of Ensysce Biosciences is ―. Ensysce Biosciences’s PEG ratio is 0.02.

In the last 12 months, Ensysce Biosciences had revenue of 5.07M and earned -10.18M in profits. Earnings per share was -3.98.

In the last 12 months, operating cash flow was -9.60M and capital expenditures -123.64K, giving a free cash flow of -9.72M billion.

Ensysce Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Ensysce Biosciences upcoming earnings date is Aug 19, 2026, After Close (Confirmed).

Ensysce Biosciences as a current ratio of 1.59, with Debt / Equity ratio of -72.30%

In the past 12 months, Ensysce Biosciences has paid 0.00 in taxes.

Ensysce Biosciences EV to EBITDA ratio is -30.21K, with an EV/FCF ratio of -0.04.

Ensysce Biosciences has $745.48K in cash and marketable securities with $245.85K in debt, giving a net cash position of $499.63K billion.

Gross margin is -103.66%, with operating margin of -202.12%, and net profit margin of -200.84%.

The average price target for Ensysce Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―